Kura Oncology
Kura Oncology is a biopharmaceutical company based in San Diego, specializing in the development of precision medicines for cancer treatment, with a focus on innovative therapies like Ziftomenib and Tipifarnib.
Company History
Kura Oncology is headquartered in San Diego, CA with additional locations in Boston, MA. The company concentrates on developing precision medicines designed to treat cancer. Since its establishment, Kura Oncology has focused on expanding patient populations and utilizing smart treatment combinations to prevent tumors from developing resistance.
Therapies
Kura Oncology is engaged in the development of investigational therapies, including Ziftomenib and Tipifarnib. These therapies are part of the company's effort to innovate and enhance cancer treatment options. The precision medicines are designed to effectively target and treat specific types of cancer.
Clinical Trials
Kura Oncology conducts clinical trials focusing on a range of cancers. These include acute leukemias, head and neck cancer, and other solid tumors. By engaging in rigorous clinical research, the company aims to bring effective treatments to market, addressing significant unmet medical needs.
Workplace and Benefits
Kura Oncology offers a competitive compensation package to its employees. This includes health, wellness, and financial benefits, aimed at ensuring a supportive and rewarding work environment. The company values its workforce and provides benefits that contribute to their overall well-being.